Blog

Parkinson-like neurotoxicity in female patients treated with Ide-cel

Photo from Samer Al Hadidi/X

Jul 30, 2024, 12:38

Parkinson-like neurotoxicity in female patients treated with Ide-cel

Samer Al Hadidi, Assistant Professor at UAMS Myeloma Center, shared a post on X, about a recent paper titled ”Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel” published in HemaSphere.

Authors: Audrey Couturier, Martine Escoffre, Frédérique Leh, Anne-Sophie Villoteau, Xavier Palard, Florence Le Jeune, Olivier Decaux, Thierry Lamy, Roch Houot.

Samer Al Hadidi

”Parkinson-like neurotoxicity in female patients treated with idecabtagene-vicleucel.

Nice summary tables of reported Parkinson-like neurotoxicity with BCMA CAR-T.

Such rare AEs occur with idecabtagene-vicleucel as well asciltacabtagene autoleucel – important for informed consent.”

Samer Al Hadidi

Source: Samer Al Hadidi/X

Anne-Sophie Villoteau asciltacabtagene autoleucel Audrey Couturier cancer cancer treatment Florence Le Jeune Frédérique Leh HemaSphere idecabtagene vicleucel Martine Escoffre Olivier Decaux OncoDaily Oncology Roch Houot Samer Al Hadidi Thierry Lamy UAMS Myeloma Center Xavier Palard

Mark Ruffalo and Brain Cancer: How He Went Against, How He Survived, and More

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

FDA approves Methotrexate for Pediatric acute Lymphoblastic Leukemia

Special Coverage